Our Blog

Emerging New Role Of Contract Development And Manufacturing

Today the global biopharma industry is transcending rapidly. We are seeing ever-increasing efforts in bringing monoclonal antibody-based biologic…

Read More

Kemwell Biopharma Selected To Manufacture The Monoclonal Antibody Drug Substance For A US Phase 3 Clinical Trial

BANGALORE, India, June 5, 2018 /PRNewswire/ -- Kemwell Biopharma, a biologics contract development and manufacturing service provider, announced…

Read More

New at Kemwell

A collection of stories about our people, our capabilities, our research,
and the ever-changing face of our firm.

Uncategorized

Madhava Ram Paranandi, Sr. Director, MSATM Scale-up of a cell culture…

Read More
Case Study

With the recent advances in biotechnology, there has been a considerable…

Read More
Uncategorized

Kemwell, a leading contract manufacturing organization, has been working on projects…

Read More

Get in Touch

    Kemwell Pharma